Peter Crane
@peterkcrane
Let me tell you about Phenomic AI, our first investment in AI drug discovery back in 2018. It's called Phenomic because it was initially using computer vision to run phenotypic analysis of potential cancer treatments––think "Recursion for biologics". After layering in single-cell
Great points from Jamie Macfarlane Vishal Gulati (I back scientists) Michael Bronstein Air Street Capital. Improved + faster spin out deals - AND removing “quasi monopolistic” funding arrangements to bring true competition and choice would be transformative. Already recommended by spinout review…
Loved working with Adam Cribbs on this! One crucial omission though: if you're in London, every other month our meetings result in a few beers to talk all things #singlecell and #sequencing ;) We're always looking for extras!